ArticleJournal of reproductive immunology2025
Do progesterone receptor membrane components (PGRMC)s play a role in the chorions refractoriness to epithelial-to-mesenchymal transition (EMT)?
Article in Journal of reproductive immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Fetal membrane inflammation is one of the drivers of adverse pregnancy outcomes. One of the reported pathways of inflammation is epithelial-mesenchymal transition (EMT) of amniotic epithelial cells. EMT is resisted during gestation via signaling initiated by the binding of progesterone (P4) to progesterone receptor membrane components (PGRMC1/PGRMC2). The vulnerability of chorionic trophoblast cells (CTCs) to transition has not been studied. Here, we examined CTCs EMT in response to the stressors and the role of PGRMC1/PGRMC2. CTCs were treated with the autophagy inhibitor bafilomycin (Baf), transforming growth factor beta (TGF-β, EMT-inducer), and lipopolysaccharide (LPS) to simulate cellular stressors associated with an adverse pregnancy environment. The primary endpoints included morphological evidence of EMT, N-cadherin-to-E-cadherin ratio, vimentin/cytokeratin staining, pro-inflammatory cytokine and P4 production. PGRMC1/PGRMC2 knock-out (KO) CTCs were prepared using CRISPR/Cas9, and experiments were repeated to test the influence of the P4-PGRMC axis. Wild-type CTCs were resistant to cellular transitions, changes in P4 production, and shifts in the inflammatory status under normal, LPS, or TGF-β conditions. Autophagy inhibition tended to cause CTCs to transition (morphological changes; high N-cadherin-to-E-cadherin ratio [p < 0.05], no change in vimentin/cytokeratin), though a complete transition was not evident. Further, neither PGRMC1/PGRMC2 played a role in CTC cellular transitions, as their KO did not cause any major changes. Chorion cells resist EMT to minimize inflammation and to maintain their barrier functions regardless of the presence of PGRMC1/ PGRMC2. Cellular stressors or infectious antigens are likely to impact the amnion, where membrane weakening can be initiated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.